Panacea recalls vaccine lot over expiry concerns
This article was originally published in Scrip
Executive Summary
Panacea Biotec is recalling a batch of around 18,000 vials of its pentavalent pediatric vaccine in southern India, after local regulators flagged up concerns over what they claim may be an unauthorized label change extending the expiry date of the concerned vaccines by a year.